Anti-ACES/ AChE/ ACHE monoclonal antibody

Anti-ACES/ AChE/ ACHE antibody for FACS & in-vivo assay

Target products collectionGo to AChE/ACHE products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T30082-Ab-1/ GM-Tg-hg-T30082-Ab-2Anti-Human AChE/ACHE monoclonal antibodyHuman
GM-Tg-rg-T30082-Ab-1/ GM-Tg-rg-T30082-Ab-2Anti-Rat AChE/ACHE monoclonal antibodyRat
GM-Tg-mg-T30082-Ab-1/ GM-Tg-mg-T30082-Ab-2Anti-Mouse AChE/ACHE monoclonal antibodyMouse
GM-Tg-cynog-T30082-Ab-1/ GM-Tg-cynog-T30082-Ab-2Anti-Cynomolgus/ Rhesus macaque AChE/ACHE monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T30082-Ab-1/ GM-Tg-felg-T30082-Ab-2Anti-Feline AChE/ACHE monoclonal antibodyFeline
GM-Tg-cang-T30082-Ab-1/ GM-Tg-cang-T30082-Ab-2Anti-Canine AChE/ACHE monoclonal antibodyCanine
GM-Tg-bovg-T30082-Ab-1/ GM-Tg-bovg-T30082-Ab-2Anti-Bovine AChE/ACHE monoclonal antibodyBovine
GM-Tg-equg-T30082-Ab-1/ GM-Tg-equg-T30082-Ab-2Anti-Equine AChE/ACHE monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T30082-Ab-1/ GM-Tg-hg-T30082-Ab-2; GM-Tg-rg-T30082-Ab-1/ GM-Tg-rg-T30082-Ab-2;
GM-Tg-mg-T30082-Ab-1/ GM-Tg-mg-T30082-Ab-2; GM-Tg-cynog-T30082-Ab-1/ GM-Tg-cynog-T30082-Ab-2;
GM-Tg-felg-T30082-Ab-1/ GM-Tg-felg-T30082-Ab-2; GM-Tg-cang-T30082-Ab-1/ GM-Tg-cang-T30082-Ab-2;
GM-Tg-bovg-T30082-Ab-1/ GM-Tg-bovg-T30082-Ab-2; GM-Tg-equg-T30082-Ab-1/ GM-Tg-equg-T30082-Ab-2
Products NameAnti-AChE/ACHE monoclonal antibody
Formatmab
Target NameAChE
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-AChE benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species ACES/ AChE/ ACHE VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLPm005042mouse Ache Lentivirus plasmid
    ORF Viral VectorvGMLPm005042mouse Ache Lentivirus particle


    Target information

    Target IDGM-T30082
    Target NameAChE
    Gene ID43,11423,83817,713370,489828,493674,540446,100069149
    Gene Symbol and SynonymsACEE,ACHE,ARACHE,N-ACHE,YT
    Uniprot AccessionP22303,P37136,O62763,P23795
    Uniprot Entry NameACES_HUMAN,ACES_RAT,ACES_FELCA,ACES_BOVIN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseAsthma, Metabolic, neurobehavioral deficits, OP toxicity, Stress reaction, Toxicity and mortality in estuarine fish, Alzheimer's, decrease in birth weight
    Gene EnsemblENSG00000087085
    Target ClassificationN/A

    The target: AChE, gene name: ACHE, also named as ACEE, ARACHE, N-ACHE, YT. Acetylcholinesterase hydrolyzes the neurotransmitter, acetylcholine at neuromuscular junctions and brain cholinergic synapses, and thus terminates signal transmission. It is also found on the red blood cell membranes, where it constitutes the Yt blood group antigen. Acetylcholinesterase exists in multiple molecular forms which possess similar catalytic properties, but differ in their oligomeric assembly and mode of cell attachment to the cell surface. It is encoded by the single ACHE gene, and the structural diversity in the gene products arises from alternative mRNA splicing, and post-translational associations of catalytic and structural subunits. The major form of acetylcholinesterase found in brain, muscle and other tissues is the hydrophilic species, which forms disulfide-linked oligomers with collagenous, or lipid-containing structural subunits. The other, alternatively spliced form, expressed primarily in the erythroid tissues, differs at the C-terminal end, and contains a cleavable hydrophobic peptide with a GPI-anchor site. It associates with the membranes through the phosphoinositide (PI) moieties added post-translationally. AChE activity may constitute a sensitive biomarker of RBC ageing in vivo, and thus, may be of aid in understanding the effects of transfusion[provided by RefSeq, Sep 2019].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.